BIM
CELG

Bridgecreek Investment Management’s Celgene Corp CELG Stock Holding History

Bridgecreek Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-39,000
Closed -$4.07M – 124
2017
Q4 		$4.07M Sell
39,000
-10,725
-22% -$1.21M 0.96% 52
2017
Q3 		$7.25M Sell
49,725
-35
-0.1% -$4.77K 1.97% 19
2017
Q2 		$6.46M Buy
49,760
+410
+0.8% +$50.2K 1.73% 22
2017
Q1 		$6.14M Sell
49,350
-4,435
-8% -$531K 1.67% 25
2016
Q4 		$6.23M Sell
53,785
-170
-0.3% -$18.9K 1.76% 23
2016
Q3 		$5.64M Sell
53,955
-355
-0.7% -$38.4K 1.69% 27
2016
Q2 		$5.36M Buy
54,310
+3,815
+8% +$395K 1.65% 28
2016
Q1 		$5.05M Buy
50,495
+4,740
+10% +$488K 1.63% 32
2015
Q4 		$5.48M Buy
45,755
+7,041
+18% +$815K 1.74% 27
2015
Q3 		$4.19M Buy
38,714
+514
+1% +$63.8K 1.25% 44
2015
Q2 		$4.42M Sell
38,200
-1,265
-3% -$145K 1.11% 46
2015
Q1 		$4.55M Buy
+39,465
New +$4.72M 1.07% 51

Other funds holding CELG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bridgecreek Investment Management's CELG Position: Q1 2018 in Review

Bridgecreek Investment Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 39,000 shares — an estimated $4.07M sold.

Bridgecreek Investment Management first reported a position in CELG in Q1 2015 and held it in 12 quarters. The position peaked at $7.25M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Bridgecreek Investment Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Bridgecreek Investment Management sold 39,000 Celgene Corp shares in Q1 2018, an estimated $4.07M.
  • Bridgecreek Investment Management first reported a position in Celgene Corp in Q1 2015 and held it in 12 quarters.
  • Bridgecreek Investment Management's Celgene Corp position peaked at $7.25M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Bridgecreek Investment Management's 13F filing for Q1 2018, filed 25 Apr 2018.